Arrayit Corporation
524 East Weddell Drive
Sunnyvale,
CA 94089
United States - Map
Phone: 408-744-1331
Fax: 408-744-1711
Web Site: http://www.arrayit.com
| Arrayit Corporation develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation, biological function, and diagnostics. It offers microarray tools and components, and diagnostic microarrays and tools, as well as engages in custom printing and analysis of microarrays for research. The companys products include microarrayers, microarray scanners, DNA and protein microarrays, microarray printing technology, brand labeling kits, DNA purification kits, buffers and solutions, microarray cleanrooms, microarray substrates and slides, microarray instruments, microarray books, and comparative genomic hybridization microarrays. It also provides labeling and purification kits, microarray tools, buffers and solutions, books and software, and microarray platform. Arrayit Corporation offers its tools and services to genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government agencies, and biotechnology companies. The company sells its products through distributors in South America, Europe, Japan, the Middle East, South Africa, China, Singapore, Korea, India, Taiwan, and Israel. Arrayit Corporation was founded in 1993 and is headquartered in Sunnyvale, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Ms. Rene A. Schena , 46
Chairman, Chief Exec. Officer and Acting Principal Accounting Officer |
$
45.00K | N/A | Dr. Mark Schena Ph.D., 45
Pres, Chief Science Officer, Sec., Treasurer |
$
0 | N/A | Mr. William L. Sklar , 60
Chief Financial Officer |
$
0 | N/A | Mr. Todd J. Martinsky , 43
Sr. VP |
$
0 | N/A | Mr. Glenn Kaplan ,
Head of Bus. Devel. of TeleChem International Inc |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.29% Nasdaq 
Profile
